Tissue inhibitor of metalloproteinase: Difference between revisions
Content deleted Content added
→External links: Renamed to "references" |
Anypodetos (talk | contribs) m Hatnote |
||
| Line 1: | Line 1: | ||
{{Redirect|TIMP|the drug metabolite|Thioinosine monophosphate}} |
|||
The [[matrix metalloproteinase]]s are inhibited by specific endogenous '''tissue inhibitors of metalloproteinases''' (TIMPs), which comprise a family of four protease inhibitors: ''[[TIMP1]]'', ''[[TIMP2]]'', ''[[TIMP3]]'' and ''[[TIMP4]]''. |
The [[matrix metalloproteinase]]s are inhibited by specific endogenous '''tissue inhibitors of metalloproteinases''' (TIMPs), which comprise a family of four protease inhibitors: ''[[TIMP1]]'', ''[[TIMP2]]'', ''[[TIMP3]]'' and ''[[TIMP4]]''. |
||
Revision as of 11:44, 23 June 2012
The matrix metalloproteinases are inhibited by specific endogenous tissue inhibitors of metalloproteinases (TIMPs), which comprise a family of four protease inhibitors: TIMP1, TIMP2, TIMP3 and TIMP4.
Overall, all MMPs are inhibited by TIMPs once they are activated but the gelatinases (MMP-2 and MMP-9) can form complexes with TIMPs when the enzymes are in the latent form.
The complex of latent MMP-2 (pro-MMP-2)with TIMP-2 serves to facilitate the activation of pro-MMP-2 at the cell surface by MT1-MMP (MMP-14), a membrane-anchored MMP.
The role of the pro-MMP-9/TIMP-1 complex is still unknown.
References
- Tissue+Inhibitor+of+Metalloproteinases at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Brew K, Dinakarpandian D, Nagase H (2000). "Tissue inhibitors of metalloproteinases: evolution, structure and function". Biochim Biophys Acta. 1477 (1–2): 267–83. doi:10.1016/S0167-4838(99)00279-4. PMID 10708863.
{{cite journal}}: CS1 maint: multiple names: authors list (link)